Senior insider sale
SVP, Chief Accounting Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$39.2K
4.79K shares
What this filing means
SABATINI BRENT plans to sell 4.79K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $39.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001441
Officer· SVP, Chief Accounting Officer
Since Feb 2026
4.79K
Shares to sell
$39.2K
Approx. market value
1.43K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
1.43KTotal acquired1.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 1.43K | — |
| Total | 1.43K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.83K
Market value
$13.6K
2/23/2026
—Completed
Units to sell
1.53K
Market value
$11.9K
2/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.43K
Market value
$13.6K
2/24/2026
Total
Units
4.79K
Value
$39.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/23/2026 | 1.83K | $13.6K | — | Completed |
2/13/2026 | 1.53K | $11.9K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 1.43K | $13.6K | NASDAQ | Planned |
| Total | 4.79K | $39.2K | ||